Denmark, Finland, Norway and Sweden all meet the technical requirements to host a pilot fusion reactor, but Finland is the most prepared in terms of regulatory readiness, according to a report ...

Researchers are hoping the data revealed by the UKNEHS pilot will lead to a national study of vision and hearing loss being ...

Glucagon-like peptide-1 drugs appear to slow the speed at which alcohol enters the bloodstream, which diminishes its effects ...

Australia’s first psychedelic trial for treatment-resistant depression has uncovered potential markers that could predict ...

Amid a documented shortage of behavioral and mental health service providers in large urban areas, the use of VR simulations ...

A study has found Finland, Sweden, Denmark, and Norway capable of hosting fusion reactors, with Finland leading in regulatory ...

The idea of a child dying by suicide is unimaginable. Yet, according to recent data, a significant number of children will ...

Among underserved and minority children with high-risk asthma, remote therapeutic monitoring was deemed feasible and met with ...

The research showed that semaglutide drugs, known as GLP-1 agonists, slow the speed at which alcohol enters the bloodstream.

The National Institutes of Health has renewed its investment in the Delaware IDeA Network of Biomedical Research Excellence ...

Lack and colleagues showed that introducing peanut products in infancy reduced the future risk of developing food allergies ...

Novatron Fusion Group aims to build a pilot fusion reactor in the Nordics in the 2030s, with Finland leading in regulatory ...